FREE BETA hCG SCREENING OF HYDROPIC AND NON-HYDROPIC TURNER SYNDROME PREGNANCIES
- 1 September 1996
- journal article
- case report
- Published by Wiley in Prenatal Diagnosis
- Vol. 16 (9), 853-856
- https://doi.org/10.1002/(sici)1097-0223(199609)16:9<853::aid-pd945>3.0.co;2-9
Abstract
Fourteen cases of Turner syndrome (45,X), two cases of mosaic Turner syndrome (45,X/47,XXX and 45,X/ 46,XX), and one case of Turner syndrome involving an isochromosome X [46,X,i(X)(q10)] were ascertained by prenatal maternal serum alpha-fetoprotein (MSAFP) and free beta human chorionic gonadotropin (hCG) screening or by ultrasound. Patient-specific risks for Down syndrome were calculated and used as the criteria to determine offering further testing. Eleven of the 17 cases had hydrops and presented with an increased Down syndrome risk based on MSAFP and free beta hCG screening. The median MOM level was 0.98 and 4.04 for MSAFP and free beta hCG, respectively. Three cases had hydrops but screened negative. The two cases of mosaic Turner syndrome were non-hydropic and screened positive. The 46,X,i(X)(q10) case was non-hydropic but had elevated MSAFP and free beta hCG levels. These data suggest that Turner syndrome pregnancies do not appear to screen positive due to hydrops alone, but screening may also be influenced by the inherent genetic imbalance in the fetus and placenta. Because the MSAFP levels in our series were within the normative range in all except one case with an elevated MSAFP, free beta hCG alone was the most effective screening marker for Turner syndrome pregnancies.Keywords
This publication has 10 references indexed in Scilit:
- Multiple marker screen positivity in the presence of hydrops fetalisPrenatal Diagnosis, 1994
- Maternal serum free beta hCG screening: Results of studies including 480 cases of down syndromePrenatal Diagnosis, 1994
- Detection of fetal Turner syndrome with multiple-marker screeningAmerican Journal of Obstetrics and Gynecology, 1994
- Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotrophin.BMJ, 1993
- The use of free β‐hCG in antenatal screening for Down's syndromeBJOG: An International Journal of Obstetrics and Gynaecology, 1993
- Antenatal screening for Down's syndrome.BMJ, 1992
- Multiple-marker screening in pregnancies with hydropic and nonhydropic Turner syndromeAmerican Journal of Obstetrics and Gynecology, 1992
- Free Beta Human Choriogonadotropin in Down's Syndrome Screening: A Multicentre Study of its Role Compared with other Biochemical MarkersAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1992
- Early Detection of Down's Syndrome Using Free Beta Human ChoriogonadotropinAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1992
- Maternal serum Down syndrome screening: Free β-protein is a more effective marker than human chorionic gonadotropinAmerican Journal of Obstetrics and Gynecology, 1990